首页|中医"肺肠合治"法联合双歧杆菌活菌胶囊在重症肺炎合并胃肠功能障碍患者中的应用效果

中医"肺肠合治"法联合双歧杆菌活菌胶囊在重症肺炎合并胃肠功能障碍患者中的应用效果

扫码查看
目的 分析中医"肺肠合治"法联合双歧杆菌活菌胶囊在重症肺炎合并胃肠功能障碍患者中的应用效果.方法 回顾性分析2019年6月至2023年6月该院重症监护室(ICU)收治的153例重症肺炎合并胃肠功能障碍患者的临床资料,根据不同治疗方案分为研究组(77例)和对照组(76例).所有患者均接受基础治疗,对照组采用双歧杆菌活菌胶囊治疗,研究组在对照组基础上联合中医"肺肠合治"法治疗.比较两组基线资料、相关评分[急性生理学与慢性健康评价Ⅱ(APACHE Ⅱ)评分、序贯性脏器衰竭评价(SOFA)评分、胃肠功能衰竭(GIF)评分、临床肺部感染量表(CPIS)评分]、胃肠功能指标[胃泌素(GAS)、胃动素(MTL)、D-乳酸、二胺氧化酶(DAO)]、炎症指标[降钙素原(PCT)、C反应蛋白(CRP)]、病死率.结果 研究组ICU停留、机械通气时间明显短于对照组,治疗后两组氧合指数(PaO2/FiO)均高于治疗前,且研究组均高于对照组,差异均有统计学意义(P<0.05).治疗后两组APACHE Ⅱ评分、SOFA评分、GIF评分、CPIS评分及GAS、D-乳酸、DAO、PCT、CRP水平均低于治疗前,且研究组均低于对照组,差异均有统计学意义(P<0.05).治疗后,两组MTL水平均高于治疗前,且研究组均高于对照组,差异均有统计学意义(P<0.05).两组病死率比较,差异无统计学意义(P>0.05).结论 在双歧杆菌活菌胶囊基础上联合中医"肺肠合治"法能有效缩短患者ICU停留、机械通气时间,改善PaO2/FiO,恢复胃肠功能,降低炎症指标水平.
Application effect of traditional Chinese medicine"lung intestinal combined treatment"combined with bifidobacterium live bacteria capsule in patients with severe pneumonia complicated with gastrointestinal dysfunction
Objective To explore the application effect of traditional Chinese medicine"lung intestinal combined treatment"combined with bifidobacterium live bacteria capsule in patients with severe pneumonia complicated with gastrointestinal dysfunction.Methods The clinical data of 153 patients with severe pneumo-nia complicated with gastrointestinal dysfunction admitted to the intensive care unit(ICU)of this hospital from June 2019 to June 2023 were retrospectively analyzed,and they were divided into study group(77 cases)and control group(76 cases)according to different treatment regiments.All patients received basic treatment,the control group was treated with bifidobacterium live bacteria capsule,and the research group was treated with traditional Chinese medicine"lung intestinal combined treatment"on the basis of the control group.Baseline data and relevant scores[Acute Physiological And Chronic Health Conditions Ⅱ(APACHE Ⅱ)score,Sequential Organ Failure Assessment(SOFA)score,Gastrointestinal Failure(GIF)score,Clinical Pul-monary Infection Scale(CPIS)score],gastrointestinal function indicators[gastrin(GAS),motilin(MTL),D-lactic acid,diamine oxidase(DAO)],inflammatory indicators[procalcitonin(PCT),C-reactive protein(CRP)],mortality were compared between the two groups.Results The duration of ICU stay and mechanical ventilation in the study group were significantly shorter than those in the control group,and the oxygenation index(PaO2/FiO)in the two groups after treatment was higher than that before treatment,and it in the study group was higher than that in the control group,and the differences were statistically significant(P<0.05).After treatment,APACHE Ⅱ score,SOFA score,GIF score,CPIS score and the levels of GAS,D-lactic acid,DAO,PCT and CRP in two groups were lower than before treatment,and those in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).After treatment,the MTL level of the two groups was higher than before treatment,and that in the study group was higher than that in the control group,and the differences were statistically significant(P<0.05).There was no sig-nificant difference in mortality between the two groups(P>0.05).Conclusion Based on bifidobacterium live bacteria capsule combined with traditional Chinese medicine"lung intestinal combined treatment"can effec-tively shorten the ICU stay and mechanical ventilation time of patients,improve PaO2/FiO,restore gastroin-testinal function and reduce the level of inflammation indicators.

lung intestinal combined treatmentbifidobacterium live bacteria capsulesevere pneumo-niagastrointestinal dysfunctionmechanical ventilation

王忆梅、张宇成、朱怡栋、张高峰

展开 >

江苏省常熟市中医院重症医学科,江苏苏州 215516

肺肠合治 双歧杆菌活菌胶囊 重症肺炎 胃肠功能障碍 机械通气

2025

检验医学与临床
重庆市卫生信息中心 重庆市临床检验中心

检验医学与临床

影响因子:1.096
ISSN:1672-9455
年,卷(期):2025.22(1)